Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Return on Sales: 2021-2025

Historic Return on Sales for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to 0.17%.

  • Cellebrite DI's Return on Sales rose 99.00% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year increase of 99.00%. This contributed to the annual value of -0.71% for FY2024, which is 46.00% down from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Return on Sales is 0.17%, which was up 148.44% from -0.35% recorded in Q2 2025.
  • Cellebrite DI's Return on Sales' 5-year high stood at 0.63% during Q3 2022, with a 5-year trough of -0.82% in Q3 2024.
  • Over the past 3 years, Cellebrite DI's median Return on Sales value was -0.29% (recorded in 2024), while the average stood at -0.30%.
  • Per our database at Business Quant, Cellebrite DI's Return on Sales crashed by 82bps in 2023 and then soared by 99bps in 2025.
  • Over the past 5 years, Cellebrite DI's Return on Sales (Quarterly) stood at 0.27% in 2021, then rose by 17bps to 0.45% in 2022, then tumbled by 70bps to -0.25% in 2023, then crashed by 46bps to -0.71% in 2024, then surged by 99bps to 0.17% in 2025.
  • Its Return on Sales stands at 0.17% for Q3 2025, versus -0.35% for Q2 2025 and -0.46% for Q1 2025.